Article Information
vol. 5 no. 1
PubMed
Published By
Online ISSN
History
- Received December 18, 2018
- Accepted December 19, 2018
- Published online February 25, 2019.
Copyright & Usage
Copyright ©ERS 2019 This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
Author Information
- Tom M.A. Wilkinson1,2,3,
- Emmanuel Aris4,
- Simon C. Bourne1,5,
- Stuart C. Clarke1,3,
- Mathieu Peeters4,
- Thierry G. Pascal4,
- Laura Taddei6,
- Andrew C. Tuck7,
- Viktoriya L. Kim1,2,
- Kristoffer K. Ostridge1,2,
- Karl J. Staples1,2,3,
- Nicholas P. Williams1,2,
- Anthony P. Williams3,
- Stephen A. Wootton8 and
- Jeanne-Marie Devaster4⇑
- on behalf of the AERIS Study Group9
- Jeanne-Marie Devaster, GSK Vaccines, Rue de l'Institut 89, 1330 Rixensart, Belgium. E-mail: jeanne-marie.devaster{at}gsk.com.
- 1Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK
- 2Southampton NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Southampton, UK
- 3Wessex Investigational Sciences Hub, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK
- 4GSK, Wavre, Belgium
- 5Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital, Portsmouth, UK
- 6GSK, Sienna, Italy
- 7Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK
- 8Southampton NIHR Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK
- 9Members of the AERIS Study Group are listed in the Acknowledgements section
Funding
GlaxoSmithKline